Buy Pfizer India; target of Rs 4800: Anand Rathi
Anand Rathi is bullish on Pfizer India has recommended buy rating on the stock with a target price of Rs 4800 in its research report dated February 10, 2023.
Latest News from Moneycontrol.com
Anand Rathi is bullish on Pfizer India has recommended buy rating on the stock with a target price of Rs 4800 in its research report dated February 10, 2023.
Latest News from Moneycontrol.com
Your Technology Source, Your Technology Team
Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more
Contact Us: contact@crwetech.com
Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tube gives corporations and businesses a vehicle to expand their exposure
CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform
Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!
Contact Us: contact@crweworld.com